Randomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non-small cell lung cancer and an Eastern Cooperative Oncology Group performance status of 2.
Saved in:
| Title: | Randomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non-small cell lung cancer and an Eastern Cooperative Oncology Group performance status of 2. |
|---|---|
| Authors: | Spigel, David R.1,2 dspigel@tnonc.com, Hainsworth, John D.1,2, Joseph, Mathew J.1,2, Shipley, Dianna L.1,2, Hagan, M. Kelly3, Thompson, Dana S.1,2, Burris, III, Howard A.1,2, Greco, F. Anthony1,2, Burris, Howard A 3rd1,2 |
| Source: | Cancer (0008543X). May2018, Vol. 124 Issue 9, p1982-1991. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
